As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC, the flagship journal of the American College of Cardiology, ...

“But the widespread use for weight-loss drugs mimicking the FDA-approved versions has gotten more out of ... traveler You ...

The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...

Drug manufacturers have increased their production, and some such as Novo Nordisk have asked the FDA to ban further production of compounded versions of their drugs. If that happens, Lavin says many ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC, the ...

This isn’t the first study to link GLP-1s to reduced alcohol intake, according to Dr. Sue Decotiis, MD, a weight-loss doctor ...

Should he make it through the nomination process, Kennedy plans to follow Trump’s mandate to remove “corruption” from HHS-led ...

Here, five nutrition experts review seven foods and drinks to limit or avoid when taking Ozempic and why reducing them may ...

they have gained infamy for their dramatic weight loss effects (in the States, the FDA has approved them to help tackle obesity). A clinical trial published in the New England Journal of Medicine, ...